Skip to main content

Loading market ticker...

Wockhardt (NSE: WOCKPHARMA) Retreats From Record Highs; Is the Rally Cooling Off?

Wockhardt (NSE: WOCKPHARMA) Retreats From Record Highs; Is the Rally Cooling Off?

Source: shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn More

Highlights

  • WOCKPHARMA declined over 7% as profit booking emerged near recent highs.
  • The stock remains well above its 50-day SMA despite the sharp correction.
  • RSI cooled from elevated levels, indicating moderation in momentum.

Overview

Wockhardt (NSE: WOCKPHARMA) came under pressure on June 5, with the stock falling 7.15% to ₹1,924.70. The decline follows a powerful rally that lifted the stock from around ₹1,200.00 in March to above ₹2,300.00 in recent sessions. After such a steep advance, traders appeared to lock in gains, leading to a sharp pullback from record highs. Despite the decline, the stock continues to trade comfortably above key medium-term trend indicators.

Fundamental View

For the quarter ended March 2026, Wockhardt reported total income of ₹57,100.00 lakh. Profit before tax stood at ₹16,700.00 lakh, while net profit also came in at ₹16,700.00 lakh. Earnings per share were reported at ₹10.29. The latest quarterly numbers reflected profitability, although the recent stock movement appears to be driven primarily by technical factors and profit booking following the stock's substantial rally.

Technical View

WOCKPHARMA closed at ₹1,924.70, significantly above its 50-day SMA of ₹1,509.19, indicating that the broader trend remains positive. The stock had been in a strong uptrend over the past two months, forming a sequence of higher highs and higher lows. However, the latest session produced a large bearish candle after rejection from the ₹2,300.00–₹2,350.00 zone. The decline suggests that near-term momentum has weakened as traders reassess positions following the rapid rise.

Momentum Indicator

The 14-day RSI eased to 60.83 after recently moving into overbought territory. While the indicator remains above the neutral 50 level, the decline reflects cooling momentum and a reduction in bullish intensity. Traders may watch whether RSI stabilizes near current levels or continues to drift lower.

Key Technical Levels

The immediate support zone is placed near ₹1,917.10, which marks the session low and the first area buyers may attempt to defend. Below this, the next important support is situated around ₹1,800.00, where previous breakout activity was observed. On the upside, resistance is visible near ₹2,071.60, followed by the recent peak zone around ₹2,350.00. A recovery above these levels would be needed to revive the stock's upward momentum.

Risks to Watch

  • Extended profit booking after the recent rally.
  • Failure to hold above near-term support zones.
  • Increased volatility following sharp price swings.
  • Weakening momentum indicators after overbought readings.

Summary

Wockhardt has entered a corrective phase after an exceptional rally that pushed the stock to record highs. Although the latest decline reflects profit booking and softer momentum, the broader trend remains constructive as the stock trades well above its 50-day SMA of ₹1,509.19. The key question for traders is whether support near ₹1,917.10 can hold. Sustaining above that level could lead to consolidation, while a break lower may trigger a deeper retracement toward the next support area.

FAQs

Why did Wockhardt shares fall today?

The stock witnessed profit booking after a sharp multi-week rally and faced selling pressure near record highs.

Is the broader trend still positive?

Yes. WOCKPHARMA remains well above its 50-day SMA of ₹1,509.19 despite the latest correction.

What levels should traders watch?

Support is seen near ₹1,917.10 and ₹1,800.00, while resistance is located around ₹2,071.60 and ₹2,350.00.

Unlock Premium Articles for Exclusive Insights!

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

Copyright 2026 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.